Skip to content

PHARMANAUS: what changed

BE 0475.087.489NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
-€10,886
2024 · -€6,955-€3,930
Equity
€633,235
2024 · €644,120-€10,886
Cash
€44,645
2024 · €67,074-€22,429
Balance sheet total
€1.2m
2024 · €1.2m-€14,175

Largest movements

2024 to 2025
Assets
  • Cash -€22,429

    down €22,429 (-33.4%), from €67,074 to €44,645

    mainly Current investments (-€16,485) and Net result for the year (-€10,886)

  • Current investments +€16,485

    up €16,485 (+1.5%), from €1.1m to €1.1m

Equity and liabilities

No liability line moved by more than 1% of the balance sheet total.

    Income statement
    • Gross operating margin -€5,870

      down €5,870, from €3,142 to -€2,729

    • Depreciation -€1,587

      down €1,587 (-13.7%), from €11,560 to €9,973

    • Taxes -€342

      down €342 (-40.6%), from €842 to €500

    • Financial charges +€262

      up €262 (+1.7%), from €15,013 to €15,275

    • Financial income +€165

      up €165 (+0.9%), from €18,186 to €18,351

    Change in the result, 2024 to 2025

    effect on the result

    For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

    Result 2024 -€6,955
    Gross operating margin -€5,870
    Depreciation +€1,587
    Other operating charges +€107
    Financial income +€165
    Financial charges -€262
    Taxes +€342
    Result 2025 -€10,886
    raises the resultlowers the result

    Derived cash bridge

    cash 2024 to 2025

    The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

    From operations -€5,944
    Investment -€16,485
    Financing €0
    Cash 2024 €67,074
    Net result for the year -€10,886
    Depreciation +€9,973
    Receivables within one year -€1,500
    Deferred charges and accrued income -€243
    Trade debts +€30
    Tax, wage and social debts -€2,008
    Other debts -€1,430
    Accrued charges and deferred income +€119
    Current investments -€16,485
    Cash 2025 €44,645
    brings cash intakes cash out
    Every line side by side 37 lines
    Line Code 2024 2025 Change %
    Total assets 20/58 €1,192,366 €1,178,191 -€14,175 -1.2%
    Fixed assets 21/28 €34,214 €24,241 -€9,973 -29.1%
    Tangible fixed assets 22/27 €34,214 €24,241 -€9,973 -29.1%
    Furniture and vehicles 24 €34,214 €24,241 -€9,973 -29.1%
    Current assets 29/58 €1,158,152 €1,153,950 -€4,202 -0.4%
    Amounts receivable within one year 40/41 €5,663 €7,163 +€1,500 +26.5%
    Trade receivables 40 €5,663 €5,663 = 0.0%
    Other amounts receivable 41 - €1,500 +€1,500
    Current investments 50/53 €1,084,416 €1,100,901 +€16,485 +1.5%
    Cash at bank and in hand 54/58 €67,074 €44,645 -€22,429 -33.4%
    Deferred charges and accrued income 490/1 €999 €1,242 +€243 +24.3%
    Total equity and liabilities 10/49 €1,192,366 €1,178,191 -€14,175 -1.2%
    Equity 10/15 €644,120 €633,235 -€10,886 -1.7%
    Contributions 10/11 €388,600 €388,600 = 0.0%
    Reserves 13 €255,300 €244,300 -€11,000 -4.3%
    Distributable reserves 133 €255,300 €244,300 -€11,000 -4.3%
    Profit (loss) carried forward 14 €220 €335 +€114 +52.0%
    Amounts payable 17/49 €548,246 €544,957 -€3,289 -0.6%
    Amounts payable within one year 42/48 €535,146 €531,738 -€3,408 -0.6%
    Trade debts 44 €1,306 €1,336 +€30 +2.3%
    Suppliers 440/4 €1,306 €1,336 +€30 +2.3%
    Taxes, remuneration and social security 45 €4,377 €2,369 -€2,008 -45.9%
    Taxes 450/3 €4,377 €2,369 -€2,008 -45.9%
    Other amounts payable 47/48 €529,463 €528,033 -€1,430 -0.3%
    Accrued charges and deferred income 492/3 €13,100 €13,219 +€119 +0.9%
    Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €11,560 €9,973 -€1,587 -13.7%
    Other operating charges 640/8 €868 €760 -€107 -12.4%
    Gross operating margin 9900 €3,142 -€2,729 -€5,870
    Operating profit (loss) 9901 -€9,286 -€13,462 -€4,176 -45.0%
    Financial income 75/76B €18,186 €18,351 +€165 +0.9%
    Recurring financial income 75 €18,186 €18,351 +€165 +0.9%
    Financial charges 65/66B €15,013 €15,275 +€262 +1.7%
    Recurring financial charges 65 €15,013 €15,275 +€262 +1.7%
    Profit (loss) for the period before taxes 9903 -€6,113 -€10,385 -€4,272 -69.9%
    Income taxes 67/77 €842 €500 -€342 -40.6%
    Profit (loss) for the period 9904 -€6,955 -€10,886 -€3,930 -56.5%
    Profit (loss) for the period to be appropriated 9905 -€6,955 -€10,886 -€3,930 -56.5%

    Value

    latest balance sheet 31-12-2025 · indication, not a valuation or advice

    Indicative value of the equity

    Indication, not a valuation or advice
    €633,235 to €633,235

    Midpoint €633,235 · adjusted equity only

    Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

    Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

    Adjusted equity €633,235
    Indication €633,235

    Adjusted equity

    balance sheet 31-12-2025
    Equity (10/15)
    €633,235
    Revaluation of assets
    €0
    Deferred tax on the revaluation
    €0
    Other adjustment
    €0
    Adjusted equity
    €633,235

    Capitalised earnings

    net result for the year (9904)
    2025
    -€10,886
    2024
    -€6,955
    2023
    €2,633
    excluding non-recurring income and charges
    -€6,499
    2022
    €385
    excluding non-recurring income and charges
    €5,735
    2021
    €128,431
    excluding non-recurring income and charges
    -€9,454
    Average result, excluding non-recurring income and charges
    -€8,113
    Divided by the capitalisation rate
    14% / 12% / 10%
    Capitalised earnings
    not meaningful, as the average result is zero or negative

    Limits of the indication

    • Checked holds no market prices or comparable transactions.
    • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
    • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
    • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
    • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

    For a valuation to base a decision on, go to a company auditor or a certified accountant.

    Calculation and sources

    Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 20 November 2026 via checked.be.